Foundation for
Applied
Research in
Gastrointestinal
Oncology



The Foundation for Applied Research in Gastrointestinal Oncology (FARGO) is a non-profit 501 (c)(3) organization that promotes research, education and patient care in gastrointestinal oncology. FARGO's primary objective is to facilitate the transfer of basic science research into innovations in patient care. The responsibilities of FARGO include financial support, administrative support, and space for continued progress in the prevention and treatment of gastrointestinal cancer.

Donations to FARGO are tax deductible and can be made to:

FARGO
c/o Washington Hospital Center
106 Irving St., NW
Suite 3900
Washington, D.C. 20010

 


FARGO was created in 1993 by Dr. Paul Sugarbaker and the FARGO Board of Directors. Current FARGO staff include:

Paul Sugarbaker, M.D.
Dal Yoo, M.D.
Gerald Parker, M.D.
Neil Otchin, M.D.
Joy Midman

Renaldo Savady, M.D.
Peter Lipresti, Esq.
Donald Farren, CPA

President
Vice President
Member, Board of Directors
Member, Board of Directors
Member, Board of Directors

Secretary-Treasurer
Legal Counsel
Accountant


A major goal of FARGO is the transfer of basic science research into improvements in patient care. The primary means to accomplish this transfer of information is the publication and presentation of research. FARGO supported in-part 32 publications in 2006. There were 9 exhibits and poster presentations and 12 speaking engagements by persons sponsored by FARGO.



A Message From the President of FARGO

Again, 2007 FARGO initiatives reached new plateaus.  The concept of peritoneal surface malignancy as a condition with curative treatment options has emerged for the medical oncologist, gastroenterologist and surgeon.  New peritoneal surface malignancy treatment centers are being organized on a monthly basis throughout the USA, Europe, Eastern Europe and Asia. Protocols to extend cytoreductive surgery and perioperative intraperitoneal chemotherapy to ovarian cancer have been initiated at several institutions including Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center.

Prospective multi-institutional standardized clinical pathways with pooled data management and reporting are increasingly difficult (IRB and HIPAA regulations).  However, further international collaborative efforts need to be initiated in colon cancer, gastric cancer, and now extended into ovarian cancer.  Although reimbursement issues continue to be a barrier to full utilization, the medical politics blocking an attack on peritoneal surface dissemination seems to have markedly decreased.

 

Our Mission

The Foundation for Applied Research in Gastrointestinal Oncology (FARGO) is a non-profit 501 (c)(3) organization that is intended to promote research, education, and patient care in gastrointestinal cancer. FARGO’s outreach is world wide. The Foundation’s major goal is to implement the transfer of basic science research to innovations in patient care. The responsibilities of FARGO are to provide financial support, administrative support, and space for continued progress in the prevention and treatment of gastrointestinal cancer.